Effects of danazol and lynestrenol on serum lipoproteins in endometriosis

Clin Pharmacol Ther. 1980 Nov;28(5):602-4. doi: 10.1038/clpt.1980.209.

Abstract

The treatment of endometriosis with danazol or lynestrenol decreased cholesterol content of plasma high-density lipoproteins by 50% and 32%. There were simultaneous increases in low-density lipoprotein cholesterol content of 51% and 19%. We suggest that changes induced by lynestrenol are due to progestational activity, while in the case of danazol both antigonadotropic and androgenic activities are involved.

MeSH terms

  • Adult
  • Danazol / pharmacology*
  • Endometriosis / blood*
  • Endometriosis / drug therapy
  • Female
  • Humans
  • Lipoproteins / blood*
  • Lynestrenol / pharmacology*
  • Pregnadienes / pharmacology*

Substances

  • Lipoproteins
  • Pregnadienes
  • Danazol
  • Lynestrenol